A Department of Health and Human Services (HHS) official recently sent a letter to Anne Milgram, Drug Enforcement Administration (DEA) Administrator, recommending that DEA reclassify marijuana from Schedule I to Schedule III. Under the Controlled Substances Act, Schedule I covers …
HHS Recommends DEA Reclassify Marijuana to Schedule III Read more »
President Biden recently issued on Executive Order (EO) on Strengthening Access to Affordable, High-Quality Contraception and Family Planning Services. The EO directs the Treasury, Labor, and Health and Human Services (HHS) Secretaries to “consider new guidance to ensure private health …
Biden Issues Executive Order on Access to Contraception Read more »
The U.S. Federal Trade Commission (FTC) is proposing to amend its Health Breach Notification Rule (HBNR; 16 C.F.R. 318). The HBNR currently requires vendors of personal health records (PHR) and related entities not covered by the Health Insurance Portability and …
FTC Proposed Amendments to Health Breach Notification Rule Read more »
The U.S. Food and Drug Administration (FDA) “is proposing to amend its human prescription drug labeling regulations to require a new type of Medication Guide – ‘Patient Medication Information’ – for prescription drug products used, dispensed, or administered on an …
FDA Proposed Rule on “Patient Medication Information” Guide Read more »
With the 5/11/2023 end of the COVID-19 national emergency and public health emergency (PHE) declarations, there will be changes to the US healthcare system. The US Centers for Medicare & Medicaid Services (CMS) website provides a comprehensive Coronavirus Disease 2019 …
Healthcare Changes Coming After End of COVID-19 National & Public Health Emergencies Read more »
